Nestlé Health Science, Nestlé’s subsidiary in healthcare, is going back to shopping this year. Greg Behar, CEO of Nestle Health Science, said that they are evaluating options in the United States, Europe, China, Japan, Australia and Brazil. The target companies are those that develop products and dietary supplements used in hospitals or home health care. “I hope by the end of the year to make some acquisitions around the world. The interest is greater in countries where there is greater support of the health system”, Behar said.
Nestlé currently has 5% of its revenue coming from Brazil.
Leave a Reply